alnylam
The Associate Director, Feasibility Center of Excellence (CoE) leads the operational delivery and strategic assessment of feasibility studies for clinical trials, working across teams and using data-driven tools to optimize protocol design, site, and country selection. The role emphasizes leadership, process improvement, and innovative use of data and technology to support global study planning.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
25% above the average for this role
Senior Manager, Feasibility
Takeda Pharmaceutical Company Limited
Senior Manager, Feasibility
Takeda Pharmaceutical Company Limited
Director I, Study Feasibility
AbbVie
Feasibility Strategy & Analytics Lead
ICON plc
Director Feasibility, SMM CTCO
AstraZeneca
Clinical Project, Feasibility Analytics Manager
lifelancer